Stable Glucagon for Treatment of Hyperinsulinism
$131,102R43FY2017DKNIH
Amidebio, Llc, Louisville CO
Investigators
Abstract
SUMMARY/ABSTRACT A series of glucagon analogues will be designed, produced at milligram levels, tested for solution stability and both in vitro and in vivo activity with the goal of providing a long term treatment for hyperinsulinism.
View original record on NIH RePORTER →